These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24588905)

  • 21. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
    Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
    Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial.
    Gjefsen E; Bråten LCH; Goll GL; Wigemyr M; Bolstad N; Valberg M; Schistad EI; Marchand GH; Granviken F; Selmer KK; Froholdt A; Haugen AJ; Dagestad MH; Vetti N; Bakland G; Lie BA; Haavardsholm EA; Nilsen AT; Holmgard TE; Kadar TI; Kvien T; Skouen JS; Grøvle L; Brox JI; Espeland A; Storheim K; Zwart JA
    BMC Musculoskelet Disord; 2020 Oct; 21(1):698. PubMed ID: 33087100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No effect of 6-month intake of glucosamine sulfate on Modic changes or high intensity zones in the lumbar spine: sub-group analysis of a randomized controlled trial.
    Wilkens P; Storheim K; Scheel I; Berg L; Espeland A
    J Negat Results Biomed; 2012 Aug; 11():13. PubMed ID: 22900984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.
    Cauley JA; Black D; Boonen S; Cummings SR; Mesenbrink P; Palermo L; Man Z; Hadji P; Reid IR;
    J Bone Miner Res; 2011 May; 26(5):984-92. PubMed ID: 21542001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial.
    Cecchetti S; Pereira B; Roche A; Deschaumes C; Abdi D; Coudeyre E; Dubost JJ; Mathieu S; Malochet-Guinamand S; Tournadre A; Couderc M; Vayssade M; Daron C; Soubrier M
    Trials; 2014 Apr; 15():117. PubMed ID: 24716739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion.
    Park YS; Kim HS; Baek SW; Kong DY; Ryu JA
    Clin Orthop Surg; 2013 Dec; 5(4):292-7. PubMed ID: 24340149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.
    Roux C; Reid DM; Devogelaer JP; Saag K; Lau CS; Reginster JY; Papanastasiou P; Bucci-Rechtweg C; Su G; Sambrook PN
    Osteoporos Int; 2012 Mar; 23(3):1083-90. PubMed ID: 21975559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 'Lumbar Fusion Outcome Score' (LUFOS): a new practical and surgically oriented grading system for preoperative prediction of surgical outcomes after lumbar spinal fusion in patients with degenerative disc disease and refractory chronic axial low back pain.
    Mattei TA; Rehman AA; Teles AR; Aldag JC; Dinh DH; McCall TD
    Neurosurg Rev; 2017 Jan; 40(1):67-81. PubMed ID: 27289367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: the ZABTON-PC (zoledronic acid/androgen blockade trial on prostate cancer) study.
    Ueno S; Mizokami A; Fukagai T; Fujimoto N; Oh-Oka H; Kondo Y; Arai G; Ide H; Horie S; Ueki O; Kawaguchi K; Shimamura M; Orito M; Ishida T; Ikeda D; Namiki M
    Anticancer Res; 2013 Sep; 33(9):3837-44. PubMed ID: 24023317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
    Ding Y; Zeng JC; Yin F; Zhang CL; Zhang Y; Li SX; Liu X; Zhang C; Xue QY; Lin H; Pei FX
    Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
    Crawford BA; Kam C; Pavlovic J; Byth K; Handelsman DJ; Angus PW; McCaughan GW
    Ann Intern Med; 2006 Feb; 144(4):239-48. PubMed ID: 16490909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Relationship Between Reduced Modic Change Edema and Disability and Pain in Patients With Chronic Low Back Pain.
    Espeland A; Kristoffersen PM; Bråten LCH; Grøvle L; Grotle M; Haugen AJ; Rolfsen MP; Hellum C; Zwart JA; Storheim K; Assmus J; Vetti N
    Spine (Phila Pa 1976); 2023 Dec; 48(24):1699-1708. PubMed ID: 37759351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is immediate imaging important in managing low back pain?
    Andersen JC
    J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Chen F; Dai Z; Kang Y; Lv G; Keller ET; Jiang Y
    Osteoporos Int; 2016 Apr; 27(4):1469-1476. PubMed ID: 26556733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment.
    Hershman DL; McMahon DJ; Crew KD; Shao T; Cremers S; Brafman L; Awad D; Shane E
    J Clin Endocrinol Metab; 2010 Feb; 95(2):559-66. PubMed ID: 20022990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intradiscal Glucocorticoid Injection for Patients With Chronic Low Back Pain Associated With Active Discopathy: A Randomized Trial.
    Nguyen C; Boutron I; Baron G; Sanchez K; Palazzo C; Benchimol R; Paris G; James-Belin É; Lefèvre-Colau MM; Beaudreuil J; Laredo JD; Béra-Louville A; Cotten A; Drapé JL; Feydy A; Ravaud P; Rannou F; Poiraudeau S
    Ann Intern Med; 2017 Apr; 166(8):547-556. PubMed ID: 28319997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Reid DM; Devogelaer JP; Saag K; Roux C; Lau CS; Reginster JY; Papanastasiou P; Ferreira A; Hartl F; Fashola T; Mesenbrink P; Sambrook PN;
    Lancet; 2009 Apr; 373(9671):1253-63. PubMed ID: 19362675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study.
    Clive AO; Hooper CE; Edey AJ; Morley AJ; Zahan-Evans N; Hall D; Lyburn I; White P; Braybrooke JP; Sequeiros I; Lyen SM; Milton T; Kahan BC; Maskell NA
    PLoS One; 2015; 10(3):e0118569. PubMed ID: 25781025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics for chronic low back pain with type 1 Modic changes: a randomized double-blind, placebo-controlled trial with 1-year follow-up using Lactobacillus Rhamnosis GG.
    Jensen OK; Andersen MH; Østgård RD; Andersen NT; Rolving N
    Eur Spine J; 2019 Nov; 28(11):2478-2486. PubMed ID: 31309333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors of prolonged disability in patients with chronic low back pain and lumbar degeneration in primary care: a cohort study.
    Wilkens P; Scheel IB; Grundnes O; Hellum C; Storheim K
    Spine (Phila Pa 1976); 2013 Jan; 38(1):65-74. PubMed ID: 22718223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.